MENU
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ARS Pharmaceuticals (SPRY) Ownership - Who owns ARS Pharmaceuticals?
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis... Show more
Profile
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.69B
P/E Ratio
151.25
Total Cash
275.73M
Projected Growth
N/A
Total Debt
73K
Revenue
97.12M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.81
Total Debt/Equity
N/A
Revenue/Share
0.94 USD as % of share price
Fundamentals
SPRY
Capitalization
1.69B
P/E Ratio
151.25
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
276M
Total Cash/Share
2.81
Total Debt
73K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.94%
Revenue
97.1M
ROE
N/A
Book Value
229M
P/B Ratio
7.37
Cash Flow
N/A
Earnings
-0.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
11.00
Current Revenue Per Employee
49831.25
Dividends Per Share - Security
N/A
EBITDA
-27.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.28
Revenue To Assets
-5.64
Shares Held By Institutions
1.35B
Shares Outstanding - Current
98.2M
Total Liabilities
98.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
62.844
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com